These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 25394677)

  • 1. Resveratrol prevents pathological but not physiological cardiac hypertrophy.
    Dolinsky VW; Soltys CL; Rogan KJ; Chan AY; Nagendran J; Wang S; Dyck JR
    J Mol Med (Berl); 2015 Apr; 93(4):413-25. PubMed ID: 25394677
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Resveratrol prevents the prohypertrophic effects of oxidative stress on LKB1.
    Dolinsky VW; Chan AY; Robillard Frayne I; Light PE; Des Rosiers C; Dyck JR
    Circulation; 2009 Mar; 119(12):1643-52. PubMed ID: 19289642
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Resveratrol inhibits cardiac hypertrophy via AMP-activated protein kinase and Akt.
    Chan AY; Dolinsky VW; Soltys CL; Viollet B; Baksh S; Light PE; Dyck JR
    J Biol Chem; 2008 Aug; 283(35):24194-201. PubMed ID: 18562309
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Isorhapontigenin, a new resveratrol analog, attenuates cardiac hypertrophy via blocking signaling transduction pathways.
    Li HL; Wang AB; Huang Y; Liu DP; Wei C; Williams GM; Zhang CN; Liu G; Liu YQ; Hao DL; Hui RT; Lin M; Liang CC
    Free Radic Biol Med; 2005 Jan; 38(2):243-57. PubMed ID: 15607907
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A novel complex I inhibitor protects against hypertension-induced left ventricular hypertrophy.
    Matsumura N; Robertson IM; Hamza SM; Soltys CM; Sung MM; Masson G; Beker DL; Dyck JR
    Am J Physiol Heart Circ Physiol; 2017 Mar; 312(3):H561-H570. PubMed ID: 28062414
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Resveratrol prevents norepinephrine induced hypertrophy in adult rat cardiomyocytes, by activating NO-AMPK pathway.
    Thandapilly SJ; Louis XL; Yang T; Stringer DM; Yu L; Zhang S; Wigle J; Kardami E; Zahradka P; Taylor C; Anderson HD; Netticadan T
    Eur J Pharmacol; 2011 Oct; 668(1-2):217-24. PubMed ID: 21756902
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Stachydrine hydrochloride suppresses phenylephrine-induced pathological cardiac hypertrophy by inhibiting the calcineurin/nuclear factor of activated T-cell signalling pathway.
    Zheng J; Tian J; Wang S; Hu P; Wu Q; Shan X; Zhao P; Zhang C; Guo W; Xu M; Chen H; Lu R
    Eur J Pharmacol; 2020 Sep; 883():173386. PubMed ID: 32712088
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Resveratrol, an activator of SIRT1, upregulates AMPK and improves cardiac function in heart failure.
    Gu XS; Wang ZB; Ye Z; Lei JP; Li L; Su DF; Zheng X
    Genet Mol Res; 2014 Jan; 13(1):323-35. PubMed ID: 24535859
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pioglitazone attenuates cardiac hypertrophy in rats with salt-sensitive hypertension: role of activation of AMP-activated protein kinase and inhibition of Akt.
    Kato MF; Shibata R; Obata K; Miyachi M; Yazawa H; Tsuboi K; Yamada T; Nishizawa T; Noda A; Cheng XW; Murate T; Koike Y; Murohara T; Yokota M; Nagata K
    J Hypertens; 2008 Aug; 26(8):1669-76. PubMed ID: 18622247
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Resveratrol reverses remodeling in hearts with large, old myocardial infarctions through enhanced autophagy-activating AMP kinase pathway.
    Kanamori H; Takemura G; Goto K; Tsujimoto A; Ogino A; Takeyama T; Kawaguchi T; Watanabe T; Morishita K; Kawasaki M; Mikami A; Fujiwara T; Fujiwara H; Seishima M; Minatoguchi S
    Am J Pathol; 2013 Mar; 182(3):701-13. PubMed ID: 23274061
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hypericin Alleviates Chronic Kidney Disease-induced Left Ventricular Hypertrophy by Regulation of FGF23-FGFR4 Signaling Pathway.
    Liu M; Cheng L; Ye Q; Liu H; Shu C; Gao H; Liu X; Zhang X; Chen G
    J Cardiovasc Pharmacol; 2024 Jun; 83(6):588-601. PubMed ID: 38547517
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Retinoid X receptor agonists inhibit hypertension-induced myocardial hypertrophy by modulating LKB1/AMPK/p70S6K signaling pathway.
    Zhu J; Ning RB; Lin XY; Chai DJ; Xu CS; Xie H; Zeng JZ; Lin JX
    Am J Hypertens; 2014 Aug; 27(8):1112-24. PubMed ID: 24603314
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Exendin-4 attenuates cardiac hypertrophy via AMPK/mTOR signaling pathway activation.
    Zhou Y; He X; Chen Y; Huang Y; Wu L; He J
    Biochem Biophys Res Commun; 2015 Dec 4-11; 468(1-2):394-9. PubMed ID: 26519882
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Novel Role for Pleckstrin Homology-Like Domain Family A, Member 3 in the Regulation of Pathological Cardiac Hypertrophy.
    Liu J; Liu X; Hui X; Cai L; Li X; Yang Y; Shu S; Wang F; Xia H; Li S
    J Am Heart Assoc; 2019 Aug; 8(16):e011830. PubMed ID: 31426686
    [TBL] [Abstract][Full Text] [Related]  

  • 15. AMPK activation counteracts cardiac hypertrophy by reducing O-GlcNAcylation.
    Gélinas R; Mailleux F; Dontaine J; Bultot L; Demeulder B; Ginion A; Daskalopoulos EP; Esfahani H; Dubois-Deruy E; Lauzier B; Gauthier C; Olson AK; Bouchard B; Des Rosiers C; Viollet B; Sakamoto K; Balligand JL; Vanoverschelde JL; Beauloye C; Horman S; Bertrand L
    Nat Commun; 2018 Jan; 9(1):374. PubMed ID: 29371602
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long-term activation of adenosine monophosphate-activated protein kinase attenuates pressure-overload-induced cardiac hypertrophy.
    Li HL; Yin R; Chen D; Liu D; Wang D; Yang Q; Dong YG
    J Cell Biochem; 2007 Apr; 100(5):1086-99. PubMed ID: 17266062
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Activation of Cardiac Fibroblast Growth Factor Receptor 4 Causes Left Ventricular Hypertrophy.
    Grabner A; Amaral AP; Schramm K; Singh S; Sloan A; Yanucil C; Li J; Shehadeh LA; Hare JM; David V; Martin A; Fornoni A; Di Marco GS; Kentrup D; Reuter S; Mayer AB; Pavenstädt H; Stypmann J; Kuhn C; Hille S; Frey N; Leifheit-Nestler M; Richter B; Haffner D; Abraham R; Bange J; Sperl B; Ullrich A; Brand M; Wolf M; Faul C
    Cell Metab; 2015 Dec; 22(6):1020-32. PubMed ID: 26437603
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Enhanced hypertrophy in ob/ob mice due to an impairment in expression of atrial natriuretic peptide.
    Mascareno E; Beckles D; Dhar-Mascareno M; Siddiqui MA
    Vascul Pharmacol; 2009; 51(2-3):198-204. PubMed ID: 19560554
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Studying the Role of AMPK in Cardiac Hypertrophy and Protein Synthesis.
    Mailleux F; Beauloye C; Balligand JL; Horman S; Bertrand L
    Methods Mol Biol; 2018; 1732():321-342. PubMed ID: 29480485
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Direct and indirect interactions between calcineurin-NFAT and MEK1-extracellular signal-regulated kinase 1/2 signaling pathways regulate cardiac gene expression and cellular growth.
    Sanna B; Bueno OF; Dai YS; Wilkins BJ; Molkentin JD
    Mol Cell Biol; 2005 Feb; 25(3):865-78. PubMed ID: 15657416
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.